Want to join the conversation?
$ADSK 1Q15 10-Q: At 1Q15-end, total stockholders’ equity was $2.22Bil vs. $2.22Bil at 4Q14-end. Completed several business combinations and technology acquisitions for total cash consideration of approx. $34.8MM. These were not material to Condensed Consolidated Statement of Operations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.